• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤微环境的多样性与可塑性在癌症多药耐药中的作用

Tumor microenvironment diversity and plasticity in cancer multidrug resistance.

作者信息

Li Zhi, Yin Peihao

机构信息

Interventional Cancer Institute of Chinese Integrative Medicine, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China; Department of General surgery, Hubei Provincial Clinical Research Center for Umbilical Cord Blood Hematopoietic Stem Cells, Taihe Hospital, Hubei University of Medicine, Shiyan 442000, China.

Interventional Cancer Institute of Chinese Integrative Medicine, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China.

出版信息

Biochim Biophys Acta Rev Cancer. 2023 Nov;1878(6):188997. doi: 10.1016/j.bbcan.2023.188997. Epub 2023 Oct 12.

DOI:10.1016/j.bbcan.2023.188997
PMID:37832894
Abstract

Multidrug resistance (MDR) poses a significant obstacle to effective cancer treatment, and the tumor microenvironment (TME) is crucial for MDR development and reversal. The TME plays an active role in promoting MDR through several pathways. However, a promising therapeutic approach for battling MDR involves targeting specific elements within the TME. Therefore, this comprehensive review elaborates on the research developments regarding the dual role of the TME in promoting and reversing MDR in cancer. Understanding the complex role of the TME in promoting and reversing MDR is essential to developing effective cancer therapies. Utilizing the adaptability of the TME by targeting novel TME-specific factors, utilizing combination therapies, and employing innovative treatment strategies can potentially combat MDR and achieve personalized treatment outcomes for patients with cancer.

摘要

多药耐药(MDR)对有效的癌症治疗构成了重大障碍,而肿瘤微环境(TME)对MDR的发展和逆转至关重要。TME通过多种途径在促进MDR方面发挥积极作用。然而,一种有前景的对抗MDR的治疗方法涉及靶向TME中的特定元素。因此,这篇全面综述阐述了关于TME在促进和逆转癌症MDR中的双重作用的研究进展。了解TME在促进和逆转MDR中的复杂作用对于开发有效的癌症治疗方法至关重要。通过靶向新型TME特异性因子利用TME的适应性、采用联合疗法以及运用创新治疗策略可能对抗MDR并为癌症患者实现个性化治疗结果。

相似文献

1
Tumor microenvironment diversity and plasticity in cancer multidrug resistance.肿瘤微环境的多样性与可塑性在癌症多药耐药中的作用
Biochim Biophys Acta Rev Cancer. 2023 Nov;1878(6):188997. doi: 10.1016/j.bbcan.2023.188997. Epub 2023 Oct 12.
2
Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.肿瘤微环境和上皮间质转化作为克服肿瘤多药耐药的靶点。
Drug Resist Updat. 2020 Dec;53:100715. doi: 10.1016/j.drup.2020.100715. Epub 2020 Jun 20.
3
The multi-factorial nature of clinical multidrug resistance in cancer.癌症临床多药耐药性的多因素性质。
Drug Resist Updat. 2019 Sep;46:100645. doi: 10.1016/j.drup.2019.100645. Epub 2019 Sep 17.
4
Autophagy and multidrug resistance in cancer.癌症中的自噬与多药耐药性
Chin J Cancer. 2017 Jun 24;36(1):52. doi: 10.1186/s40880-017-0219-2.
5
Unraveling the tumor microenvironment: Insights into cancer metastasis and therapeutic strategies.解析肿瘤微环境:洞察癌症转移和治疗策略。
Cancer Lett. 2024 Jun 1;591:216894. doi: 10.1016/j.canlet.2024.216894. Epub 2024 Apr 16.
6
Therapeutic Approaches of Dual-targeted Nanomedicines for Tumor Multidrug Resistance.肿瘤多药耐药的双靶向纳米药物治疗方法。
Curr Drug Deliv. 2024;21(2):155-167. doi: 10.2174/1567201820666230504145614.
7
The reversal of chemotherapy-induced multidrug resistance by nanomedicine for cancer therapy.纳米医学逆转癌症治疗中化疗诱导的多药耐药性。
J Control Release. 2021 Jul 10;335:1-20. doi: 10.1016/j.jconrel.2021.05.012. Epub 2021 May 12.
8
[Study of antisense oligodeoxynucleotide in reversing multidrug resistance and inducing apoptosis of tumor cells].反义寡脱氧核苷酸逆转肿瘤细胞多药耐药及诱导凋亡的研究
Zhonghua Xue Ye Xue Za Zhi. 1997 Dec;18(12):627-9.
9
Advances in traditional herbal formulation based nano-vaccine for cancer immunotherapy: Unraveling the enigma of complex tumor environment and multidrug resistance.基于传统草药配方的纳米疫苗在癌症免疫治疗方面的进展:揭开复杂肿瘤微环境和多药耐药性之谜。
Int Immunopharmacol. 2024 May 10;132:111948. doi: 10.1016/j.intimp.2024.111948. Epub 2024 Mar 29.
10
Improving therapeutic resistance: beginning with targeting the tumor microenvironment.提高治疗抗性:从靶向肿瘤微环境开始。
J Chemother. 2022 Dec;34(8):492-516. doi: 10.1080/1120009X.2021.2011661. Epub 2021 Dec 7.

引用本文的文献

1
Mechanistic Foundations of KRAS-Driven Tumor Ecosystems: Integrating Crosstalk among Immune, Metabolic, Microbial, and Stromal Microenvironment.KRAS驱动的肿瘤生态系统的机制基础:整合免疫、代谢、微生物和基质微环境之间的相互作用
Adv Sci (Weinh). 2025 Jun 9:e02714. doi: 10.1002/advs.202502714.
2
Exercise therapy: an effective approach to mitigate the risk of cancer metastasis.运动疗法:降低癌症转移风险的有效方法。
World J Surg Oncol. 2025 May 16;23(1):192. doi: 10.1186/s12957-025-03846-7.
3
Gut microbiota and their influence in brain cancer milieu.
肠道微生物群及其在脑癌微环境中的影响。
J Neuroinflammation. 2025 May 1;22(1):129. doi: 10.1186/s12974-025-03434-2.
4
Identification and validation of a lenvatinib resistance-related prognostic signature in HCC, in which PFKFB4 contributes to tumor progression and lenvatinib resistance.肝癌中乐伐替尼耐药相关预后特征的鉴定与验证,其中磷酸果糖激酶-2/果糖-2,6-二磷酸酶4(PFKFB4)促进肿瘤进展和乐伐替尼耐药。
BMC Gastroenterol. 2025 Apr 23;25(1):287. doi: 10.1186/s12876-025-03861-8.
5
RNA modifications in the tumor microenvironment: insights into the cancer-immunity cycle and beyond.肿瘤微环境中的RNA修饰:对癌症免疫循环及其他方面的见解
Exp Hematol Oncol. 2025 Apr 2;14(1):48. doi: 10.1186/s40164-025-00648-1.
6
Central nervous system and immune cells interactions in cancer: unveiling new therapeutic avenues.癌症中中枢神经系统与免疫细胞的相互作用:揭示新的治疗途径。
Front Immunol. 2025 Feb 28;16:1528363. doi: 10.3389/fimmu.2025.1528363. eCollection 2025.
7
Glycolysis reprogramming in CAFs promotes oxaliplatin resistance in pancreatic cancer through circABCC4 mediated PKM2 nuclear translocation.癌症相关成纤维细胞中的糖酵解重编程通过circABCC4介导的丙酮酸激酶M2型核转位促进胰腺癌对奥沙利铂的耐药性。
Cell Death Dis. 2025 Feb 23;16(1):126. doi: 10.1038/s41419-025-07431-4.
8
DKK1+ tumor cells inhibited the infiltration of CCL19+ fibroblasts and plasma cells contributing to worse immunotherapy response in hepatocellular carcinoma.DKK1+ 肿瘤细胞抑制 CCL19+ 成纤维细胞和浆细胞的浸润,导致肝细胞癌的免疫治疗反应更差。
Cell Death Dis. 2024 Nov 7;15(11):797. doi: 10.1038/s41419-024-07195-3.
9
The Role of Intracellular and Extracellular Vesicles in the Development of Therapy Resistance in Cancer.细胞内和细胞外囊泡在癌症治疗抵抗发展中的作用。
Curr Pharm Des. 2024;30(35):2765-2784. doi: 10.2174/0113816128326325240723051625.
10
Recent advances in understanding the immune microenvironment in ovarian cancer.卵巢癌免疫微环境研究进展。
Front Immunol. 2024 Jun 5;15:1412328. doi: 10.3389/fimmu.2024.1412328. eCollection 2024.